The Chicago Entrepreneur

Pfizer’s drug for advanced lung cancer shows promising long-term trial results

The company’s medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for over five years.

Previous post FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
Next post Aston Martin gets a boost from Formula 1 and new high-performance models